Thrombosomes as an antiplatelet agent reversal agent
US11701388B2 · kind B2 · utility
7Cited by
56References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 14, 2020 |
| Grant date | Jul 18, 2023 |
| Priority date | — |
| Expiry date | Dec 13, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In some embodiments provided herein is a method of treating a coagulopathy in a subject, the method including administering to the subject in need thereof an effective amount of a composition including platelets or platelet derivatives and an incubating agent including one or more salts, a buffer, optionally a cryoprotectant, and optionally an organic solvent, wherein the subject has been treated or is being treated with an antiplatelet agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.